These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11925804)
1. [Information about cancer treatment and the media]. van Dam FS; Renckens CN Ned Tijdschr Geneeskd; 2002 Mar; 146(11):524-5. PubMed ID: 11925804 [TBL] [Abstract][Full Text] [Related]
2. Problems with media gatekeepers. Nature; 1998 May; 393(6681):97. PubMed ID: 9603503 [No Abstract] [Full Text] [Related]
3. [The story of angiostatin and how controversy is useful in science]. Kurjak A Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695 [TBL] [Abstract][Full Text] [Related]
4. Cancer "breakthrough" is still in the future. Health News; 1998 Jun; 4(7):6. PubMed ID: 9624918 [No Abstract] [Full Text] [Related]
5. Cancer 'cure' article stirs up hot debate. Wadman M Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508 [No Abstract] [Full Text] [Related]
7. Are angiostatin and endostatin cures for cancer? Harris AL Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709 [No Abstract] [Full Text] [Related]
8. Angiogenesis: the unifying concept in cancer? Saphir A J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530 [No Abstract] [Full Text] [Related]
9. [Angiostatin and its antitumor activity]. Félez J; Jardí M; Arza B Med Clin (Barc); 2000 Mar; 114(11):431-6. PubMed ID: 10786363 [No Abstract] [Full Text] [Related]
10. [Study on the antitumor effect of angiostatin on LA795 adenocarcinoma cells]. Zheng F; Tong W; Wen J Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):34-6. PubMed ID: 11778179 [TBL] [Abstract][Full Text] [Related]
11. Shouting 'cure!'--or whispering 'hope'--in a crowded cancer ward. Healy BP J Womens Health; 1998 Jun; 7(5):489-90. PubMed ID: 9650147 [No Abstract] [Full Text] [Related]
12. [Tumor angiogenesis inhibitors: media and scientific aspects]. Raymond E Presse Med; 1998 Jul 4-11; 27(24):1221-4. PubMed ID: 9767782 [TBL] [Abstract][Full Text] [Related]
13. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors. Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903 [TBL] [Abstract][Full Text] [Related]
14. Scientists, media should not overstate 'breakthroughs'. Salmon S Ann Oncol; 1998 Aug; 9(8):794-5. PubMed ID: 9789598 [No Abstract] [Full Text] [Related]
15. [Progress in the lung cancer therapy with angiogenesis inhibitors]. Bai C; Ma T Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):306-7. PubMed ID: 11326959 [No Abstract] [Full Text] [Related]
16. The promise of anti-angiogenic cancer therapy. Oehler MK; Bicknell R Br J Cancer; 2000 Feb; 82(4):749-52. PubMed ID: 10732738 [No Abstract] [Full Text] [Related]
17. A new approach to fighting cancer? Sato TN Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880 [No Abstract] [Full Text] [Related]